EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A narrative review of theophylline: is there still a place for an old friend?

Martin Scurek iD, Kristian Brat iD

Journal of Thoracic Disease · 2024-05 · 16 (5) · 3450-3460

DOI: 10.21037/jtd-23-1781 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thoracic Disease, 2024-05. Verfasst von Martin Scurek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Theophylline has been used for decades in human medicine for its psychostimulant, anti-inflammatory, and bronchodilator effects. Historically, in pulmonary medicine, theophylline has been used in the treatment of obstructive pulmonary diseases such as bronchial asthma (BA) or chronic obstructive pulmonary disease (COPD). This review aims to determine whether theophylline still has its place in the therapy of obstructive pulmonary diseases or whether we can even extend its use to other diagnoses such as atropine-resistant cardiac arrests, apnea of prematurity, or others. Moreover, we also aim to determine if there is a rationale for using low-dose theophylline due to its immunomodulatory and anti-inflammatory effect, or if the future of methylxanthines lies in newly synthesized derivates of theophylline such as bamifylline, or doxofylline.

Methods

The narrative review is based on a literature search of the articles indexed in the PubMed database in 2023. We searched the database since the year 2009 using the MeSH terms "theophylline", "aminophylline", and "methylxanthines" and we included original articles in the English language. Key Content and Findings: Theophylline has a number of adverse drug reactions (ADRs), the most serious of which is its effect on the cardiovascular system. It can cause severe arrhythmias or even cardiac arrest when overdosed. On the other hand, there is still a substantial amount of its applications in current clinical practice.

Conclusions

There is considerable controversy associated with its use in current medicine, which can be attributed both to its narrow therapeutic range and its mentioned cardiotoxic effect. Herein, we summarize the current state-of-art of theophylline and its use in human medicine.

Schlagwörter

Stichwörter der Autor:innen

Theophyllineaminophyllinebronchial asthma (BA)chronic obstructive pulmonary disease (COPD)methylxanthines

Autor:innen und Institutionen

  • Department of Respiratory Diseases, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.
  • International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia.

ORCID-Profile: Martin Scurek, Kristian Brat

Zitieren

APA

Scurek, M., & Brat, K. (2024). A narrative review of theophylline: is there still a place for an old friend?. Journal of Thoracic Disease, 16(5), 3450-3460. https://doi.org/10.21037/jtd-23-1781

Vancouver

Scurek M, Brat K. A narrative review of theophylline: is there still a place for an old friend?. Journal of Thoracic Disease. 2024;16(5):3450-3460. doi:10.21037/jtd-23-1781

BibTeX
@article{Scurek2024,
  author = {Scurek, Martin and Brat, Kristian},
  title = {A narrative review of theophylline: is there still a place for an old friend?},
  journal = {Journal of Thoracic Disease},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {3450--3460},
  doi = {10.21037/jtd-23-1781}
}
Kostenlos starten →